| abstract |
The present invention relates to a pharmaceutical composition for treating inflammatory diseases, comprising: a compound represented by chemical formula I, a pharmaceutically acceptable salt thereof; a hydrate thereof; or a compound as a solvate thereof, as active ingredients. According to the present invention, provided are a compound which interacts with a 5-LOX-pathway and interrupts the 5-LOX-pathway and, especially, a compound having an effect for inhibiting arachidonate 5-lipoxygenase. |